© Reuters. 93-year-old Shari Marco receives a fourth dose of the coronavirus disease (COVID-19) vaccine following a vaccination party after Israel approved a second booster shot for the immunocompromised, people over 60 years and medical staff in a retirement home i
JERUSALEM (Reuters) – A fourth shot of COVID-19 vaccine boosts antibodies to even higher levels than the third jab but it likely is not enough to prevent Omicron infections, according to a preliminary study in Israel.
The vaccines led to a increase in the number of antibodies “even a little bit higher than what we had after the third dose”, said Regev-Yochay, adding that the results were preliminary and not yet published.
Israel was the fastest country to roll out initial vaccinations a year ago and last month started offering a fourth shot, or a second booster, to the most vulnerable, high-risk groups.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Russia bans Biden but not Trump, on list of Americans travel-barred
President Donald Trump and Russian President Vladimir Putin arrive for a joint news conference after their meeting in Helsinki, July…
HSBC banker’s remarks on climate risk inconsistent with strategy, CEO says By Reuters
© Reuters. FILE PHOTO: HSBC CEO Noel Quinn attends the UN Climate Change Conference (COP26) in Glasgow, Scotland, Britain, November…